Why ADMET & DMPK Analysis is Critical for R&D Success
ADMET analysis and DMPK analysis are essential for predicting a drug candidate’s behavior in the body and minimizing risks in clinical development.
At transMedChem Consulting, we specialize in ADMET and DMPK analysis services, offering in-depth pharmacokinetics analysis and pharmacokinetics and pharmacodynamics services.
By integrating early profiling strategies, we help our clients identify liabilities, optimize compounds, and enhance the probability of clinical success.
Our comprehensive approach ensures informed decision-making from early discovery through preclinical and clinical phases.
Our ADMET & DMPK Analysis Services
We deliver end-to-end ADMET and DMPK support tailored to drug discovery projects, ensuring a strong foundation for lead optimization and candidate nomination.
In Vitro ADMET Screening
Performing early assays for absorption, metabolism, permeability, and toxicity to guide compound refinement.
In Vivo Pharmacokinetics Studies
Conducting PK studies in relevant models to evaluate absorption, distribution, metabolism, and clearance.
DMPK Strategy Development
Designing tailored DMPK strategies to align with discovery goals and regulatory expectations.
Drug-Drug Interaction (DDI) Risk Assessment
Predicting potential drug-drug interactions through enzyme inhibition, induction, and transporter studies.
Bioanalytical Method Development
Supporting preclinical and clinical studies with robust bioanalytical assay development and validation.
Pharmacokinetics and Pharmacodynamics Integration
Linking PK and PD data to optimize dosing strategies, efficacy, and safety profiles.
Specialized Expertise in ADMET and DMPK Analysis
Our ADMET and DM